Serum peptides as candidate biomarkers for dementia with Lewy bodies

Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias

(2013) Megan K. Herbert et al.   Alzheimers & Dementia

Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease

(2013) Miwa Noguchi et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies

(2013) T. J. Ferman et al.   NEUROLOGY

Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease

(2011) Christopher B. Forsyth et al.   PLoS One

Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn’s disease

(2010) Moriaki Hatsugai et al.   JOURNAL OF GASTROENTEROLOGY

Fibrinogen and β-Amyloid Association Alters Thrombosis and Fibrinolysis: A Possible Contributing Factor to Alzheimer's Disease

(2010) Marta Cortes-Canteli et al.   NEURON

Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies

(2008) Lucilla Parnetti et al.   BIOLOGICAL PSYCHIATRY

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?

(2008) Annika Öhrfelt et al.   NEUROSCIENCE LETTERS

Serum heart-fatty acid binding protein levels in patients with Lewy body disease

(2007) Kenji Wada-Isoe et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES